An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease

NCT01134367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2011-07-14

No results posted yet for this study

Summary

The purpose of this study is to examine patient's perspective of symptom control and impact of gastroesophageal reflux disease (GERD) on daily life.

Conditions

  • GERD

Sponsors & Collaborators

Principal Investigators

  • Miodrag Krstić, Prof.Dr · Institute for Gastroenterology, Clinical Center of Serbia, Belgrade

  • Dragomir Damjanov, Prof. Dr · Clinic for Internal Diseases, Clinical Center of Vojvodina, Novi Sad

  • Aleksandar Nagorni, Prof. Dr · Clinic for Internal Diseases- Gastroenterology Dept, Clinical Center Nis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Serbia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01134367 on ClinicalTrials.gov